Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
13.94 USD | -1.73% | -10.76% | -23.08% |
May. 14 | Sector Update: Health Care Stocks Ease in Tuesday Afternoon Trading | MT |
May. 14 | Pliant Therapeutics Reports Positive Topline Data in Idiopathic Pulmonary Fibrosis Trial | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.08% | 855M | |
+39.59% | 723B | |
+34.28% | 595B | |
-3.56% | 369B | |
+20.56% | 332B | |
+2.83% | 282B | |
+17.26% | 244B | |
+9.20% | 208B | |
-4.99% | 205B | |
+0.21% | 168B |
- Stock Market
- Equities
- PLRX Stock
- News Pliant Therapeutics, Inc.
- Pliant Therapeutics Begins Phase 2b Trial of Bexotegrast in Idiopathic Pulmonary Fibrosis